494 related articles for article (PubMed ID: 18817366)
1. Isosorbide-2-carbamate esters: potent and selective butyrylcholinesterase inhibitors.
Carolan CG; Dillon GP; Gaynor JM; Reidy S; Ryder SA; Khan D; Marquez JF; Gilmer JF
J Med Chem; 2008 Oct; 51(20):6400-9. PubMed ID: 18817366
[TBL] [Abstract][Full Text] [Related]
2. Isosorbide-2-benzyl carbamate-5-salicylate, a peripheral anionic site binding subnanomolar selective butyrylcholinesterase inhibitor.
Carolan CG; Dillon GP; Khan D; Ryder SA; Gaynor JM; Reidy S; Marquez JF; Jones M; Holland V; Gilmer JF
J Med Chem; 2010 Feb; 53(3):1190-9. PubMed ID: 20067290
[TBL] [Abstract][Full Text] [Related]
3. Isosorbide-based cholinesterase inhibitors; replacement of 5-ester groups leading to increased stability.
Dillon GP; Gaynor JM; Khan D; Carolan CG; Ryder SA; Marquez JF; Reidy S; Gilmer JF
Bioorg Med Chem; 2010 Feb; 18(3):1045-53. PubMed ID: 20093035
[TBL] [Abstract][Full Text] [Related]
4. Novel alkyl- and arylcarbamate derivatives with N-benzylpiperidine and N-benzylpiperazine moieties as cholinesterases inhibitors.
Więckowska A; Bajda M; Guzior N; Malawska B
Eur J Med Chem; 2010 Dec; 45(12):5602-11. PubMed ID: 20926161
[TBL] [Abstract][Full Text] [Related]
5. Novel isosorbide di-ester compounds as inhibitors of acetylcholinesterase.
Carolan CG; Gaynor JM; Dillon GP; Khan D; Ryder SA; Reidy S; Gilmer JF
Chem Biol Interact; 2008 Sep; 175(1-3):293-7. PubMed ID: 18571631
[TBL] [Abstract][Full Text] [Related]
6. Development of molecular probes for the identification of extra interaction sites in the mid-gorge and peripheral sites of butyrylcholinesterase (BuChE). Rational design of novel, selective, and highly potent BuChE inhibitors.
Campiani G; Fattorusso C; Butini S; Gaeta A; Agnusdei M; Gemma S; Persico M; Catalanotti B; Savini L; Nacci V; Novellino E; Holloway HW; Greig NH; Belinskaya T; Fedorko JM; Saxena A
J Med Chem; 2005 Mar; 48(6):1919-29. PubMed ID: 15771436
[TBL] [Abstract][Full Text] [Related]
7. Acetylcholinesterase inhibitors: synthesis and structure-activity relationships of omega-[N-methyl-N-(3-alkylcarbamoyloxyphenyl)- methyl]aminoalkoxyheteroaryl derivatives.
Rampa A; Bisi A; Valenti P; Recanatini M; Cavalli A; Andrisano V; Cavrini V; Fin L; Buriani A; Giusti P
J Med Chem; 1998 Oct; 41(21):3976-86. PubMed ID: 9767635
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and structure activity relationships (SAR) of a new class of potent and selective butyrylcholinesterase inhibitors.
Gaynor JM; Dillon GP; Reidy S; Gilmer JF
Chem Biol Interact; 2005 Dec; 157-158():380-1. PubMed ID: 16429505
[TBL] [Abstract][Full Text] [Related]
9. Cholinesterase inhibitors: xanthostigmine derivatives blocking the acetylcholinesterase-induced beta-amyloid aggregation.
Belluti F; Rampa A; Piazzi L; Bisi A; Gobbi S; Bartolini M; Andrisano V; Cavalli A; Recanatini M; Valenti P
J Med Chem; 2005 Jun; 48(13):4444-56. PubMed ID: 15974596
[TBL] [Abstract][Full Text] [Related]
10. Cholinesterase inhibitors: SAR and enzyme inhibitory activity of 3-[omega-(benzylmethylamino)alkoxy]xanthen-9-ones.
Piazzi L; Belluti F; Bisi A; Gobbi S; Rizzo S; Bartolini M; Andrisano V; Recanatini M; Rampa A
Bioorg Med Chem; 2007 Jan; 15(1):575-85. PubMed ID: 17008100
[TBL] [Abstract][Full Text] [Related]
11. alpha,beta-Dehydrophenylalanine choline esters, a new class of reversible inhibitors of human acetylcholinesterase and butyrylcholinesterase.
Grigoryan HA; Hambardzumyan AA; Mkrtchyan MV; Topuzyan VO; Halebyan GP; Asatryan RS
Chem Biol Interact; 2008 Jan; 171(1):108-16. PubMed ID: 17980356
[TBL] [Abstract][Full Text] [Related]
12. Cyclic acyl guanidines bearing carbamate moieties allow potent and dirigible cholinesterase inhibition of either acetyl- or butyrylcholinesterase.
Darras FH; Kling B; Sawatzky E; Heilmann J; Decker M
Bioorg Med Chem; 2014 Sep; 22(17):5020-34. PubMed ID: 25059502
[TBL] [Abstract][Full Text] [Related]
13. Novel Selective Butyrylcholinesterase Inhibitors Incorporating Antioxidant Functionalities as Potential Bimodal Therapeutics for Alzheimer's Disease.
Jones M; Wang J; Harmon S; Kling B; Heilmann J; Gilmer JF
Molecules; 2016 Apr; 21(4):440. PubMed ID: 27534722
[TBL] [Abstract][Full Text] [Related]
14. Preparation and in vitro screening of symmetrical bispyridinium cholinesterase inhibitors bearing different connecting linkage-initial study for Myasthenia gravis implications.
Musilek K; Komloova M; Zavadova V; Holas O; Hrabinova M; Pohanka M; Dohnal V; Nachon F; Dolezal M; Kuca K; Jung YS
Bioorg Med Chem Lett; 2010 Mar; 20(5):1763-6. PubMed ID: 20138518
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis and evaluation of flavonoid derivatives as potent AChE inhibitors.
Sheng R; Lin X; Zhang J; Chol KS; Huang W; Yang B; He Q; Hu Y
Bioorg Med Chem; 2009 Sep; 17(18):6692-8. PubMed ID: 19692250
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, biological evaluation, and molecular modeling of berberine derivatives as potent acetylcholinesterase inhibitors.
Huang L; Shi A; He F; Li X
Bioorg Med Chem; 2010 Feb; 18(3):1244-51. PubMed ID: 20056426
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and acetylcholinesterase and butyrylcholinesterase inhibitory activities of 7-alkoxyl substituted indolizinoquinoline-5,12-dione derivatives.
Wu ZP; Wu XW; Shen T; Li YP; Cheng X; Gu LQ; Huang ZS; An LK
Arch Pharm (Weinheim); 2012 Mar; 345(3):175-84. PubMed ID: 21989769
[TBL] [Abstract][Full Text] [Related]
18. Homo- and hetero-bivalent edrophonium-like ammonium salts as highly potent, dual binding site AChE inhibitors.
Leonetti F; Catto M; Nicolotti O; Pisani L; Cappa A; Stefanachi A; Carotti A
Bioorg Med Chem; 2008 Aug; 16(15):7450-6. PubMed ID: 18585045
[TBL] [Abstract][Full Text] [Related]
19. Specific targeting of acetylcholinesterase and butyrylcholinesterase recognition sites. Rational design of novel, selective, and highly potent cholinesterase inhibitors.
Savini L; Gaeta A; Fattorusso C; Catalanotti B; Campiani G; Chiasserini L; Pellerano C; Novellino E; McKissic D; Saxena A
J Med Chem; 2003 Jan; 46(1):1-4. PubMed ID: 12502352
[TBL] [Abstract][Full Text] [Related]
20. Novel isosorbide-based substrates for human butyrylcholinesterase.
Gilmer JF; Lally MN; Gardiner P; Dillon G; Gaynor JM; Reidy S
Chem Biol Interact; 2005 Dec; 157-158():317-9. PubMed ID: 16266694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]